azathioprine

Generic: azathioprine

Labeler: amneal pharmaceuticals ny llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name azathioprine
Generic Name azathioprine
Labeler amneal pharmaceuticals ny llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

azathioprine 100 mg/1

Manufacturer
Amneal Pharmaceuticals NY LLC

Identifiers & Regulatory

Product NDC 60219-2037
Product ID 60219-2037_7b890b18-936a-43f1-9980-e94a417762f6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074069
Listing Expiration 2026-12-31
Marketing Start 2021-11-08

Pharmacologic Class

Established (EPC)
purine antimetabolite [epc]
Mechanism of Action
nucleic acid synthesis inhibitors [moa]
Chemical Structure
nucleosides [cs] purines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 602192037
Hyphenated Format 60219-2037

Supplemental Identifiers

RxCUI
197388 359228 359229
UPC
0360219203716
UNII
MRK240IY2L
NUI
N0000000233 M0015066 N0000175712 M0018169

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name azathioprine (source: ndc)
Generic Name azathioprine (source: ndc)
Application Number ANDA074069 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (60219-2037-1)
source: ndc

Packages (1)

Ingredients (1)

azathioprine (100 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7b890b18-936a-43f1-9980-e94a417762f6", "openfda": {"nui": ["N0000000233", "M0015066", "N0000175712", "M0018169"], "upc": ["0360219203716"], "unii": ["MRK240IY2L"], "rxcui": ["197388", "359228", "359229"], "spl_set_id": ["59f3219f-898f-4d05-a430-c2b3f5255af1"], "pharm_class_cs": ["Nucleosides [CS]", "Purines [CS]"], "pharm_class_epc": ["Purine Antimetabolite [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (60219-2037-1)", "package_ndc": "60219-2037-1", "marketing_start_date": "20211108"}], "brand_name": "AZATHIOPRINE", "product_id": "60219-2037_7b890b18-936a-43f1-9980-e94a417762f6", "dosage_form": "TABLET", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleosides [CS]", "Purine Antimetabolite [EPC]", "Purines [CS]"], "product_ndc": "60219-2037", "generic_name": "Azathioprine", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AZATHIOPRINE", "active_ingredients": [{"name": "AZATHIOPRINE", "strength": "100 mg/1"}], "application_number": "ANDA074069", "marketing_category": "ANDA", "marketing_start_date": "20211108", "listing_expiration_date": "20261231"}